MEGAN VOCU: Open Payments
NPI 1730618380 · HAYES, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$406 in 21 payments from 11 companies in 2025. Trend: 2023 $353 · 2024 $302 · 2025 $406
Food & beverage: $387Education: $19
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $113 |
| AstraZeneca Pharmaceuticals LP | 4 | $62 |
| Novo Nordisk Inc | 2 | $47 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Axsome Therapeutics, Inc. | 2 | $32 |
| Shockwave Medical, Inc | 1 | $25 |
| PFIZER INC. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Exact Sciences Corporation | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: QULIPTA, Auvelity, AIRSUPRA, FARXIGA, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, UBRELVY, NURTEC ODT, JARDIANCE.
Industry payments across VA — which companies pay providers there.
